EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer

Tomasz Kubiatowski, Ewa Kalinka

Menopausal Review · 2025 · 24 (3) · 206-210

DOI: 10.5114/pm.2025.154681 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Menopausal Review, 2025. Verfasst von Tomasz Kubiatowski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ADCdatopotamab deruxtecansacituzumab govitecantrastuzumab deruxtecantriple negative breast cancer

Autor:innen und Institutionen

  • Department of Oncology, Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland.
  • Oncology Clinic with a Gynecological Oncology Subdivision of the University Hospital in Rzeszow, Poland.
  • Department of Oncology, Radiotherapy and Translational Medicine, Rzeszow University, Poland.

Zitieren

APA

Kubiatowski, T., & Kalinka, E. (2025). Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer. Menopausal Review, 24(3), 206-210. https://doi.org/10.5114/pm.2025.154681

Vancouver

Kubiatowski T, Kalinka E. Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer. Menopausal Review. 2025;24(3):206-210. doi:10.5114/pm.2025.154681

BibTeX
@article{Kubiatowski2025,
  author = {Kubiatowski, Tomasz and Kalinka, Ewa},
  title = {Antibody-drug conjugates in the treatment of advanced triple-negative breast cancer},
  journal = {Menopausal Review},
  year = {2025},
  volume = {24},
  number = {3},
  pages = {206--210},
  doi = {10.5114/pm.2025.154681}
}
Kostenlos starten →